scispace - formally typeset
E

Erik Ingelsson

Researcher at Stanford University

Publications -  546
Citations -  99427

Erik Ingelsson is an academic researcher from Stanford University. The author has contributed to research in topics: Genome-wide association study & Population. The author has an hindex of 124, co-authored 538 publications receiving 85407 citations. Previous affiliations of Erik Ingelsson include Karolinska Institutet & Cardiovascular Institute of the South.

Papers
More filters
Journal ArticleDOI

Comprehensive Investigation of Circulating Biomarkers and Their Causal Role in Atherosclerosis-Related Risk Factors and Clinical Events

TL;DR: The results suggest that it is unlikely that CRP (C-reactive protein) and vitamin D play causal roles of any meaningful magnitude in development of cardiometabolic disease.
Journal ArticleDOI

Prediction impact curve is a new measure integrating intervention effects in the evaluation of risk models.

TL;DR: A new measure of assessing the performance of risk models, the area under the prediction impact curve (auPIC), which quantifies the performanceof risk models in terms of their average health impact in the population is proposed.
Journal ArticleDOI

Use of type 2 diabetes risk scores in clinical practice: a call for action

TL;DR: The increased attention given recently to nonEuropean and US contexts is laudable, but research needs to be redirected toward replication and validation, rather than drafting of novel scores.
Journal ArticleDOI

Effects of trans10cis12CLA-induced insulin resistance on retinol-binding protein 4 concentrations in abdominally obese men

TL;DR: In this randomized, placebo-controlled, double-blind study of 57 abdominally obese middle-aged men, conjugated linoleic acid (CLA) did not induce changes in retinol-binding protein 4 concentrations (RBP4), despite marked induced insulin resistance.